Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated
Sponsor: Boehringer Ingelheim
Summary
The trial aims to study the safety, tolerability, and pharmacokinetics of single and multiple rising doses of BI 3776528.
Official title: A Two-part, Randomised, Single-blind, Placebo-controlled, Single and Multiple Rising Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of BI 3776528, Administered to Healthy Male Participants
Key Details
Gender
MALE
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
142
Start Date
2025-01-23
Completion Date
2026-08-25
Last Updated
2025-11-21
Healthy Volunteers
Yes
Conditions
Interventions
BI 3776528
BI 3776528
Placebo matching BI 3776528
Placebo matching BI 3776528
short-acting benzodiazepine
short-acting benzodiazepine
Locations (1)
Charité Research Organisation GmbH
Berlin, Germany